ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,522.30
      1.58%
      US Tech 100
      19,014.40
      3.90%
      Dow Jones
      40,842.79
      0.24%
      Brent Oil
      81.52
      0.01%
      Bitcoin
      64,431.70
      -0.26%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Vaccinex Inc (VCNX)

      7. Vaccinex Inc (VCNX) Financials

      Vaccinex Inc

      Vaccinex Inc (VCNX)

      NASDAQ
      5.10
      -2.96
      (-36.72%)
      Closed July 31 4:00PM
      Delayed by 15 minutes
      5.11
      0.01
      (0.20%)
      After Hours: 7:56PM
      Delayed by 15 minutes

      Vaccinex Inc Financial Summary

      The current VCNX market cap is 8.1M. The company's latest EPS is USD -12.7823 and P/E is -0.40.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 550k020k0104k
      Operating Income -4.99M-7.08M-5.83M-4.99M-5.07M
      Net Income -4.96M-7.06M-4.91M-3.32M-3.9M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 523k625k900k275k570k
      Operating Income -32.02M-28.33M-22.49M-19.91M-22.89M
      Net Income -31.86M-28.85M-22.38M-19.82M-20.25M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 4.9M3.09M2.56M3.63M7.37M
      Total Liabilities 2.5M3.51M6.43M5.94M4.71M
      Total Equity 2.4M-423k-3.87M-2.31M2.66M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 4.6M11.7M9.84M7.98M3.63M
      Total Liabilities 6.88M14.31M2.43M2.78M5.94M
      Total Equity -2.27M-2.61M7.41M5.19M-2.31M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -5.04M-10.55M-13.64M-17.23M-4.63M
      Investing -49k-49k-67k-67k N/A
      Financing 2.02M6.11M7.45M12.45M6.07M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -30.72M-28.65M-25.3M-19.07M-17.23M
      Investing 14.07M-290k-32k-99k-67k
      Financing 13.8M36.76M23.32M16.98M12.45M

      Stats and Ratios

      Market Cap 8.1M
      Price to Earnings Ratio -0.40
      Price to Sales Ratio 14.15
      Price to Cash Ratio 5.25
      Price to Book Ratio -3.49
      Dividend Yield -

      Share Statistics

      Shares Outstanding 1.58M
      Average Volume (1 week) 154.83k
      Average Volume (1 Month) 94.2k
      52 Week Change -91.25%
      52 Week High 64.89
      52 Week Low 4.432
      Spread (Intraday) 0.3 (5.56%)

      Company Info

      Company Name Vaccinex Inc
      Address 850 new burton road
      dover, delaware 19904
      Website https://www.vaccinex.com
      Industry pharmaceutical preparations (2834)